Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
144M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
11.7M
-
Shares change
-
-91.8K
-
Total reported value, excl. options
-
$257M
-
Value change
-
-$1.66M
-
Put/Call ratio
-
15.55
-
Number of buys
-
38
-
Number of sells
-
-24
-
Price
-
$22.01
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q4 2020
78 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q4 2020.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.7M shares
of 144M outstanding shares and own 8.12% of the company stock.
Largest 10 shareholders include FMR LLC (2.22M shares), ORBIMED ADVISORS LLC (1.77M shares), BlackRock Inc. (1.06M shares), Knoll Capital Management, LP (852K shares), ALKEON CAPITAL MANAGEMENT LLC (740K shares), VANGUARD GROUP INC (682K shares), Rock Springs Capital Management LP (636K shares), EMERALD MUTUAL FUND ADVISERS TRUST (540K shares), EMERALD ADVISERS, LLC (516K shares), and DRIEHAUS CAPITAL MANAGEMENT LLC (467K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.